Venture

My Chronic Cancer LLC | Today our InSite system is pre-FDA. InSite increases cancer patient survival and lowers direct front-end costs. InSite’s targeted worldwide cloud market is 450M+ cancer patients.

My Chronic Cancer LLC Team:

Robert Shickel